Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · IOC 2027

Ocular Surface Disease at IOC 2027

Part of the IOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Ocular Surface Disease Session

Ocular Surface Disease (OSD) encompasses a group of disorders affecting the cornea, conjunctiva, and tear film, leading to discomfort, visual disturbances, and potential damage if untreated. Common conditions under this umbrella include dry eye syndrome, blepharitis, and ocular allergies. Dry eye syndrome, the most prevalent form, results from inadequate tear production or poor tear quality, causing symptoms like itching, burning, and a gritty sensation. Blepharitis involves inflammation of the eyelid margins, often leading to redness, crusting, and irritation. Ocular allergies manifest as itching, redness, and tearing due to hypersensitivity reactions to allergens. Management strategies typically involve artificial tears, lifestyle modifications, and in more severe cases, prescription medications or procedural interventions like punctal plugs to conserve tears. Early diagnosis and tailored treatment are crucial to alleviate symptoms and prevent complications, highlighting the importance of regular eye exams for maintaining ocular health.

Topics Covered in Ocular Surface Disease

Topic 01

Meibomian Gland Dysfunction

Topic 02

Tear Film Instability

Topic 03

Allergic Conjunctivitis

Topic 04

Neurotrophic Keratopathy

Topic 05

Preservative Toxicity

Topic 06

Ocular GVHD

Related Scientific Sessions at IOC 2027

Why Attend the Ocular Surface Disease Conference 2027

Earn CPD Credit

Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.

Present Your Research

Oral and poster slots for original Ocular Surface Disease work, reviewed by the scientific committee.

Network Globally

Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.

Publish & Get Indexed

Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.

Learn from Keynotes

Plenary lectures from leading voices shaping Ocular Surface Disease research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join IOC 2027 for the Ocular Surface Disease track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Ocular Surface Disease Conference 2027 — FAQs

What is the Ocular Surface Disease track at IOC 2027?

The Ocular Surface Disease track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Ocular Surface Disease. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Ocular Surface Disease sessions?

Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Ocular Surface Disease are all welcome — whether presenting or attending.

Can I present my research in the Ocular Surface Disease track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Ocular Surface Disease sessions?

Yes. IOC 2027 is a hybrid conference — attend the Ocular Surface Disease track in person in Singapore or join live online, with on-demand access afterward.

Join the IOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us